Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug21 | 3676 | Lidocaine | NCT00982618, NCT01155440 | C14H22N2O | 234.34 | approved | YES | Details |
| Drug22 | 3705 | Indigotindisulfonic Acid | NCT01914445 | C16H10N2O8S2 | 422.40 | NULL | YES | Details |
| Drug23 | 3715 | Indomethacin | NCT05999708 | C19H16ClNO4 | 357.80 | approved|investigational | YES | Details |
| Drug24 | 3961 | Losartan | NCT02760615 | C22H23ClN6O | 422.90 | approved | YES | Details |
| Drug25 | 4030 | Mebendazole | NCT06335160 | C16H13N3O3 | 295.29 | approved | YES | Details |
| Drug26 | 4075 | Mesalazine | NCT05992142, NCT01532648, NCT02665845, NCT00603733, NCT02683759, NCT03804931, NCT01320436, NCT00984568, NCT00167882, NCT00713310, NCT01004185, NCT01903252, NCT00151892, NCT00349388, NCT05753267, NCT05781698, NCT05988528, NCT05567068, NCT05986136, NCT05119 | C7H7NO3 | 153.14 | approved | YES | Details |
| Drug27 | 4091 | Metformin | NCT05553704, NCT05574387, NCT03986996 | C4H11N5 | 129.16 | approved | YES | Details |
| Drug28 | 4173 | Metronidazole | NCT03794765, NCT04968951, NCT02606032, NCT04186247, NCT00257699, NCT00355602, NCT04979832 | C6H9N3O3 | 171.15 | approved | YES | Details |
| Drug29 | 4192 | Midazolam | NCT02760615, NCT03358706 | C18H13ClFN3 | 325.80 | approved|illicit | YES | Details |
| Drug30 | 4205 | Mirtazapine | NCT06309472 | C17H19N3 | 265.35 | approved | YES | Details |